Buoyant growth for US transcatheter device market:
This article was originally published in Clinica
The US coronary transcatheter device market is expected to grow in excess of 20% annually from $1.9 billion in 1997 to $4.8 billion in 2002, according to a new report from Medical Data International. Market growth will be boosted by new technologies which improve patient outcomes and enable previously untreatable patients to be administered with transcatheter therapies. For more details, contact Medical Data International in the US. Tel: +1 800 826 5759. Website: www.medicaldata.com
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.